SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 232 filers reported holding SAGE THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $6,483,000 | -24.1% | 114,119 | 0.0% | 0.21% | -28.2% |
| Q1 2021 | $8,542,000 | -35.1% | 114,119 | -24.9% | 0.29% | -36.4% |
| Q4 2020 | $13,153,000 | +123.7% | 152,040 | +58.0% | 0.46% | +110.0% |
| Q3 2020 | $5,880,000 | +47.0% | 96,211 | 0.0% | 0.22% | +44.7% |
| Q2 2020 | $4,000,000 | +44.8% | 96,211 | 0.0% | 0.15% | +21.6% |
| Q1 2020 | $2,763,000 | -60.2% | 96,211 | 0.0% | 0.12% | -52.5% |
| Q4 2019 | $6,945,000 | -43.0% | 96,211 | +10.9% | 0.26% | -50.5% |
| Q3 2019 | $12,174,000 | -21.0% | 86,780 | +3.1% | 0.53% | -15.6% |
| Q2 2019 | $15,406,000 | +21.3% | 84,145 | +5.4% | 0.63% | +21.9% |
| Q1 2019 | $12,701,000 | +34.7% | 79,856 | -18.9% | 0.52% | +27.7% |
| Q4 2018 | $9,430,000 | -53.5% | 98,444 | -31.5% | 0.40% | -45.1% |
| Q3 2018 | $20,285,000 | -9.8% | 143,614 | 0.0% | 0.74% | -13.7% |
| Q2 2018 | $22,480,000 | +12.0% | 143,614 | +15.2% | 0.85% | +9.2% |
| Q1 2018 | $20,077,000 | +79.7% | 124,650 | +83.8% | 0.78% | +81.2% |
| Q4 2017 | $11,170,000 | +55.0% | 67,815 | -25.0% | 0.43% | +61.4% |
| Q2 2017 | $7,206,000 | +12.1% | 90,480 | 0.0% | 0.27% | +7.2% |
| Q1 2017 | $6,430,000 | +133.2% | 90,480 | +67.6% | 0.25% | +112.8% |
| Q4 2016 | $2,757,000 | -59.2% | 54,000 | -63.2% | 0.12% | -55.0% |
| Q3 2016 | $6,760,000 | +52.8% | 146,800 | 0.0% | 0.26% | +43.6% |
| Q2 2016 | $4,423,000 | -6.0% | 146,800 | 0.0% | 0.18% | -9.5% |
| Q1 2016 | $4,706,000 | -17.5% | 146,800 | +50.1% | 0.20% | -3.4% |
| Q4 2015 | $5,702,000 | -25.4% | 97,800 | -45.8% | 0.21% | -24.7% |
| Q3 2015 | $7,643,000 | +598.0% | 180,600 | +1104.0% | 0.28% | +587.5% |
| Q2 2015 | $1,095,000 | +45.4% | 15,000 | 0.0% | 0.04% | +33.3% |
| Q1 2015 | $753,000 | +311.5% | 15,000 | +200.0% | 0.03% | +233.3% |
| Q4 2014 | $183,000 | +15.8% | 5,000 | 0.0% | 0.01% | +28.6% |
| Q3 2014 | $158,000 | – | 5,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Integral Health Asset Management, LLC | 311,000 | $10,294,000 | 2.68% |
| Palo Alto Investors LP | 851,719 | $28,192,000 | 2.18% |
| Boxer Capital, LLC | 1,094,000 | $36,211,000 | 1.86% |
| DAFNA Capital Management LLC | 180,306 | $5,968,000 | 1.56% |
| Deep Track Capital, LP | 675,000 | $22,343,000 | 1.43% |
| Bellevue Group AG | 3,052,404 | $101,034,000 | 1.17% |
| Ikarian Capital, LLC | 249,907 | $8,272,000 | 1.09% |
| Ikarian Capital, LLC | 250,000 | $8,275,000 | 1.09% |
| Artal Group S.A. | 750,000 | $24,825,000 | 1.04% |
| SECTOR GAMMA AS | 118,476 | $3,922,000 | 0.85% |